Anti-PLOD2/LH2 antibody [EPR25160-20]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- KO Validated
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Knockout Tested Rabbit Recombinant Monoclonal PLOD2/LH2 antibody. Suitable for WB, IP, IHC-P, Dot and reacts with Human, Mouse, Rat, Recombinant fragment - Human samples. Cited in 1 publication.
View Alternative Names
Lysyl hydroxylase 2, LH2, PLOD2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Immunohistochemical analysis of paraffin-embedded (A) Wild-type HEK293T tissue labeling PLOD2/LH2 with ab313765 at 1/2000 (0.252 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cytoplasmic staining on (A) Wild-type HEK293T cell pellet, no staining on (B) PLOD2 knockout HEK293T cell pellet. The section was incubated with ab313765 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Immunohistochemical analysis of paraffin-embedded Human hepatocellular tissue labeling PLOD2/LH2 with ab313765 at 1/2000 (0.252 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cytoplasmic staining on (A) human hepatocellular carcinoma tissue and (B) very weak staining on the adjacent tissue (PMID : 33014843). The section was incubated with ab313765 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Immunohistochemical analysis of paraffin-embedded Human clear cell renal tissue labeling PLOD2/LH2 with ab313765 at 1/2000 (0.252 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cytoplasmic staining on (A) human clear cell renal cell carcinoma tissue and (B) very weak staining on the adjacent tissue (PMID : 33287763). The section was incubated with ab313765 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IP
Supplier Data
Immunoprecipitation - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
PLOD2/LH2 was immunoprecipitated from 0.35 mg HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with ab313765 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab313765 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate Lane 2 : ab313765 IP in HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab313765 in HeLa whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 15 seconds
All lanes:
Immunoprecipitation - Anti-PLOD2/LH2 antibody [EPR25160-20] (ab313765) at 1/30 dilution
All lanes:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>)
false
Exposure time: 15s
- IP
Supplier Data
Immunoprecipitation - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
PLOD2/LH2 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate with ab313765 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab313765 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : NIH/3T3 (mouse embryonic fibroblast) whole cell lysate Lane 2 : ab313765 IP in NIH/3T3 (mouse embryonic fibroblast) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab313765 in NIH/3T3 whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 180 seconds
All lanes:
Immunoprecipitation - Anti-PLOD2/LH2 antibody [EPR25160-20] (ab313765) at 1/30 dilution
All lanes:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Lysates at 20 µg per lane.
The samples were run on a Bis-Tris gel under reducing conditions. Western blot : Anti-PLOD2/LH2 antibody (ab313765) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody 6C5 (ab8245) loading control staining at 1/20000 dilution, shown in red.
In Western blot, ab313765 was shown to bind specifically to PLOD2/LH2.
Target of interest was observed at 95 kDa in wild-type Hela cell lysates (lane 1) with no signal observed at this size in PLOD2 knockout cell line ab266279 (knockout cell lysate ab258591) (lane 2). To generate this image, samples were first run on an SDS-PAGE gel then transferred onto an immobilon-FL PVDF membrane. Membranes were blocked in a fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4°C. Blots were washed in TBS-T, incubated with secondary antibodies Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution for 1 h at room temperature, washed again then imaged.
All lanes:
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (ab313765) at 1/1000 dilution
Lane 1:
Wild-type HEK293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
Western blot - Human PLOD2 (PLOD2/LH2) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-plod2-plod2-lh2-knockout-hek-293t-cell-line-ab266279'>ab266279</a>)
Lane 2:
Western blot - Human PLOD2 (PLOD2/LH2) knockout HEK-293T cell lysate (<a href='/en-us/products/cell-lysates/human-plod2-plod2-lh2-knockout-hek-293t-cell-lysate-ab258591'>ab258591</a>) at 20 µg
Lane 3:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (800CW) and Goat Anti-Mouse IgG H&L (680RD) at 1/20000 dilution
Observed band size: 95 kDa
false
- WB
Supplier Data
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Exposure time : 81 seconds
All lanes:
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (ab313765) at 1/1000 dilution
Lane 1:
Human testis tissue lysate at 20 µg
Lane 2:
Human colon cancer tissue lysate at 20 µg
Lane 3:
Human liver cancer tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 95 kDa
false
Exposure time: 81s
- WB
Supplier Data
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Exposure time : Lane 1-3 : 158 seconds, Lane 4-5 : 48 seconds
All lanes:
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (ab313765) at 1/1000 dilution
Lane 1:
Caco-2 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 3:
PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 20 µg
Lane 4:
Mouse testis tissue lysate at 20 µg
Lane 5:
C2C12 (mouse myoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 95 kDa
false
Exposure time: 158s
- WB
Supplier Data
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Blocking and diluting buffer and concentration : 5% NFDM/TBST In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution. Exposure time : 26 seconds
All lanes:
Western blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (ab313765) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control, whole cell lysate at 20 µg
Lane 2:
Hela transfected with siRNA specifically targeting PLOD2, whole cell lysate at 20 µg
Lane 3:
DU 145 (human prostate carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 95 kDa
false
Exposure time: 26s
- Dot
Supplier Data
Dot Blot - Anti-PLOD2/LH2 antibody [EPR25160-20] (AB313765)
Dot blot analysis of PLOD2/LH2 using ab313765 at 1 : 1000 (0.503 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution. Exposure time : 180 seconds. Blocking and diluting buffer and concentration : 5% NFDM/TBST
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine reports 31: PubMed39513600
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com